Pembrolizumab in HER2-Positive Gastric Cancer.
Janjigian YY, Kawazoe A, Bai Y, Xu J, Lonardi S, Metges JP, Yañez P, Wyrwicz LS, Shen L, Ostapenko Y, Bilici M, Chung HC, Shitara K, Qin S, Van Cutsem E, Tabernero J, Luo S, Mahave M, Tang Y, Lowery M, Monteiro MMF, Xu L, Shih CS, Sharan KP, Bhagia P, Rha SY.
Janjigian YY, et al. Among authors: bai y.
N Engl J Med. 2024 Sep 14. doi: 10.1056/NEJMc2408121. Online ahead of print.
N Engl J Med. 2024.
PMID: 39282917
No abstract available.